Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Track record
Movers
The Lead Compound
Home
›
Targets
› PI3Kα H1047R
PI3Kα H1047R
(1 companies · 1 programs)
Companies with an active program directed at PI3Kα H1047R.
RECURSION PHARMACEUTICALS, INC.
RXRX
REC-7735
— Solid Tumors
Preclinical